Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States
Open Access
- 1 September 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 1 (6) , 700-707
Abstract
Taken at face value, current US and European cholesterol guidelines seem to have substantial differences.1-3 Although guidelines in both regions recommend statin therapy for adults with atherosclerotic cardiovascular disease (CVD), type 1 or type 2 diabetes, and possible familial hyperlipidemia, the 2011 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines for the management of dyslipidemias also recommend therapy for adults with severe hypertension and chronic kidney disease (CKD).1 In the United States, guidelines endorsed by the American College of Cardiology/American Heart Association (ACC/AHA) do not identify these groups as automatic candidates for statin therapy.2 Notably, the ACC/AHA and ESC/EAS guidelines differ in their approaches to identify high-risk adults in need of statin therapy for primary prevention, as well as those ultimately recommended statins for other reasons. The ACC/AHA guidelines use the Pooled Cohort Equations (PCE), which recommend statin therapy for adults aged 40 to 75 years with a 10-year risk of atherosclerotic CVD risk of 7.5% or more.2 The ESC/EAS guidelines use estimates developed from the Systematic Coronary Risk Evaluation (SCORE) project,4 which predicts the 10-year risk of CVD mortality for adults aged 40 to 65 years. Statins are recommended based on both low-density lipoprotein cholesterol (LDL-C) levels and a SCORE risk of 5% or more.1Keywords
This publication has 17 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2015 UpdateCirculation, 2015
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJACC, 2014
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014
- Application of New Cholesterol Guidelines to a Population-Based SampleNew England Journal of Medicine, 2014
- Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European CohortJAMA, 2014
- Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular diseaseEuropean Heart Journal, 2014
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending GapHealth Affairs, 2007
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003
- Comparison of current guidelines for primary prevention of coronary heart diseaseJournal of General Internal Medicine, 2003